Skip to content
    Reviews

    International Guidelines for Localized Rectal Cancer

    Cina et alUpdates in Surgery

    International Guidelines for Localized Rectal Cancer
    A comparative evaluation of 11 contemporary international guideline frameworks assessed localized rectal cancer management across staging, early disease, neoadjuvant treatment, total neoadjuvant therapy (TNT), radiotherapy, surgery, organ preservation, lateral pelvic lymph nodes, deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) disease, and surveillance. A prespecified critical appraisal evaluated methodological quality, clinical comprehensiveness, currency, implementability, and innovation. Formal AGREE II assessment, conducted with primary appraisal followed by second-appraiser verification, showed 100% item-level verification agreement; scope/purpose and clarity scored 100% across all frameworks, whereas substantial variation was observed in applicability (33.3%–100%) and rigour of development (64.6%–100%).
    Strong guideline convergence was identified regarding high-quality pelvic MRI staging, multidisciplinary decision-making, the standard use of total mesorectal excision (TME) when radical resection is required, TNT for MRI-defined high-risk disease, and increasing acceptance of watch-and-wait non-operative management following a rigorously documented clinical complete response. In contrast, major divergences persisted regarding favorable stage II/III disease, selective radiotherapy omission, long- versus short-course radiotherapy regimens, TNT sequencing, definitions of the upper rectum, management of near-complete responses, and lateral pelvic lymph-node surgery. In addition, the newest frameworks endorse immunotherapy-first pathways for dMMR/MSI-H locally advanced rectal cancer, introducing the potential to omit both chemoradiotherapy and TME in complete responders. Collectively, international guidance is shifting from stage-based uniformity toward risk-, biomarker-, and response-adapted pathways that determine which patients require radical resection, local treatment, or non-operative surveillance.

    Key Takeaways

    • A formal AGREE II appraisal of 11 international guideline frameworks showed 100% item-level verification agreement, with the widest score variations occurring in applicability (33.3% to 100%) and rigour of development (64.6% to 100%).
    • Guidelines converged strongly on utilizing high-quality pelvic MRI, multidisciplinary decision-making, total mesorectal excision for radical resection, total neoadjuvant therapy for MRI high-risk disease, and watch-and-wait organ preservation after documented clinical complete response.
    • Persistent divergences across guidelines involve management of favorable stage II/III disease, selective omission of radiotherapy, long- versus short-course radiotherapy, total neoadjuvant therapy sequencing, upper-rectal definitions, near-complete response handling, and lateral pelvic lymph-node surgery.
    Read the original sourceUpdates in Surgery